Viela Bio, Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$11.7M

Net Income/Loss (FY2020)

-$150.7M

Total Assets (FY2020)

$423.3M

Total Equity (FY2020)

$375.8M

Cash Flows from Operating Activities (FY2020)

-$106.1M

Source: Viela Bio, Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.